Tomoegawa Co., Ltd. agreed to acquire additional 25.2% stake in SHOEI Printing Co., Ltd. from Sakae Technical Paper Co., Ltd., Too Shoji Co., Ltd, Ozawa Pharmaceutical Co., Ltd. and other individual shareholders for approximately ¥160 million.
March 26, 2020
Share
Tomoegawa Co., Ltd. (TSE:3878) agreed to acquire additional 25.2% stake in SHOEI Printing Co., Ltd. from Sakae Technical Paper Co., Ltd., Too Shoji Co., Ltd, Ozawa Pharmaceutical Co., Ltd. and other individual shareholders for approximately ¥160 million on March 27, 2020. Upon completion, Tomoegawa Co., Ltd. will hold 0.46 million shares representing 29.61% stake in SHOEI Printing Co., Ltd. For the year ended March 2019, SHOEI Printing reported net assets of ¥2.9 billion, total assets of ¥8.3 billion, sales of ¥5.3 billion, operating income of ¥8 million, net loss of ¥183 million. The transaction was resolved by the board of director of Tomoegawa on March 27, 2020. The transaction is expected to be completed on March 30, 2020.
Tomoegawa Corp, formerly Tomoegawa Co Ltd, is a Japan-based company mainly engaged in the manufacture of toner and electronic materials, as well as paper manufacturing and coated paper-related businesses. The Company operates business through five segments. The toner segment is engaged in the production and sale of toner. The electronic materials segment is engaged in the production and sale of flat panel display (FPD) related products and semiconductor related products. The functional paper segment produces and sells paper-related products, functional paper-related products, and coated paper-related products. The security media segment is engaged in the manufacture, processing, and sale of securities, cards, forms, magnetic recording-related products, as well as information processing-related businesses. The new development business is engaged in the development and sale of new products by integrating the basic and elemental technologies owned by the group.
Tomoegawa Co., Ltd. agreed to acquire additional 25.2% stake in SHOEI Printing Co., Ltd. from Sakae Technical Paper Co., Ltd., Too Shoji Co., Ltd, Ozawa Pharmaceutical Co., Ltd. and other individual shareholders for approximately ¥160 million.
TOMOEGAWA CORPORATION 
